Linezolid som behandling af infektiøs endokarditis

Research output: Contribution to journalJournal articleResearchpeer-review

In Denmark enterococci causes 15 to 20% of all endocarditis (IE) cases. The development of multi-resistant bacterial strains has increased the need for new antibiotics. Linezolid is an alternative to conventional treatment of infections with gram positive cocci. In this case report linezolid was used to treat IE in a patient, who was allergic to penicillin and where conventional treatment caused development of acute renal failure. No side effects were observed and the patient responded well to the treatment.
Translated title of the contribution[Linezolid therapy for infectious endocarditis]
Original languageDanish
JournalUgeskrift for Laeger
Volume172
Issue number16
Pages (from-to)1215-6
Number of pages2
ISSN0041-5782
Publication statusPublished - 19 Apr 2010

ID: 34190741